A double-blind placebo-controlled pilot study of glutamine therapy for abnormal intestinal permeability in patients with AIDS

American Journal of Gastroenterology

Volumn 93, Issue 6, 1998, Pages 972-975

  Noyer, Charles M ^a   Simon, Douglas ^b   Borczuk, Alain ^b   Brandt, Lawrence J ^b   Lee, Martin J ^b   Nehra, Vandana ^b  

^a JACOBI MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DUODENUM BIOPSY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; ORAL REHYDRATION THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; DOUBLE-BLIND METHOD; EPITHELIUM; GLUTAMINE; HIV ENTEROPATHY; HUMANS; INTESTINE, SMALL; MIDDLE AGED; PERMEABILITY;

EID: 0032105409     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00290.x     Document Type: Article

References (28)

1. 1. Tanowitz HB, Simon D, Weiss LM, et al. Gastrointestinal manifestations. In: Management of the HIV-infected patient, part I. Med Clin N Amer 1996;80:1395-1414.
2. 2. Antony MA, Brandt LJ, Klein RS, et al. Infectious diarrhea in patients with AIDS. Dig Dis Sci 1988;33:1141-6.
3. 3. Gillin JC, Shike M, Alcock N, et al. Malabsorption and mucosal abnormalities of the small intestine in the acquired immunodeficiency syndrome. Ann Intern Med 1985;102:619-22.
4. 4. Miller ARO, Griffin GE, Batman P, et al. Jejunal mucosal architecture and fat absorption in male homosexuals infected with human immunodeficiency virus. Q J Med 1988;69:1009-19.
5. 5. Lim S, Menzies IS, Lee C, et al. Intestinal permeability and function in patients infected with human immunodeficiency virus. Scand J Gastroenterol 1993;28:573-80.
6. 6. Tepper RE, Simon D, Brandt LJ, et al. Intestinal permeability in patients infected with the human immunodeficiency virus. Am J Gastroenterol 1994;89:878-82.
7. 7. Bjarnason I, Macpherson AJ, Hollander D. Intestinal permeability: An overview. Gastroenterology 1995;108:1566-81.
8. 8. Howden G, Robertson C, Duncan A, et al. Comparison of different measurements of intestinal permeability in inflammatory bowel. Am J Gastroenterol 1991;86:1445-9.
9. 9. Cobden I, Dickinson RI, Rothwell J, et al. Intestinal permeability assessed by excretion ratios of two molecules: Results in coeliac disease. Br Med J 1978;2:1060.
10. 10. Juby LD, Rothwell J, Axon ATR. Cellobiose/mannitol sugar test. A sensitive tubeless test for coeliac disease: Results in 1010 unselected patients. Gut 1989;30:476-80.
11. 11. Kotler DP, Gaetz HP, Lange N, et al. Enteropathy associated with acquired immunodeficiency syndrome. Ann Intern Med 1984;101:421-8.
12. 12. Greenson K, Belitsos PC, Yardley JH, et al. AIDS enteropathy: Occult enteric infections and duodenal mucosal alterations in chronic diarrhea. Ann Intern Med 1991;114:366-72.
13. 13. Ullrich R, Riecken EO, Zeitz M. HIV-induced enteropathy. Immunol Res 1991;10:456-64.
14. 14. Anonymous. HIV-associated enteropathy. Lancet 1989;2:777-8.
15. 15. Ullrich R, Heise W, Bergs C, et al. Effects of zidovudine treatment on the small intestinal mucosa in patients infected with the human immunodeficiency virus. Gastroenterology 1992;102:1483-92.
16. 16. Windmueller HG, Spaeth AE. Identification of ketone bodies and glutamine as the major respiratory fuels in vivo for postabsorptive rat small intestine. J Biol Chem 1978;253:69-76.
17. 17. Newsholme EA, Crabtree B, Ardawi MSM. Glutamine metabolism in lymphocytes: Its biochemical, physiological and clinical importance. Q J Exper Physiol 1985;70:473-89.
18. 18. Hall JC, Heel K, McCauley R. Glutamine. Br J Surg 1996;83:305-12.
19. 19. Shabert JK, Wilmore DW. Glutamine deficiency as a cause of human immunodeficiency virus wasting. Med Hypoth 1996;46:252-6.
20. 20. Tremel H, Kienle B, Weilemeann LS, et al. Glutamine dipeptide-supplemented parenteral nutrition maintains intestinal function in the critically ill. Gastroenterology 1994;107:1595-601.
21. 21. Wiren M, Magnusson K-E, Larsson J. Enteral glutamine increases growth and absorptive capacity of intestinal mucosa in the malnourished rat. Scand J Gastroenterol 1995;30:146-52.
22. 22. Ziegler TR, Young LS, Benfell K, et al. Clinical metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind controlled study. Ann Intern Med 1992;116:821-8.
23. 23. Schloerb PR, Amare M. Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study). JPEN J Parenter Enteral Nutr 1993;17:407-13.
24. 24. Scheppach W, Loges C, Bartram P, et al. Effect of free glutamine and alanyl-glutamine dipeptide on mucosal proliferation of the human ileum and colon. Gastroenterology 1994;107:429-34.
25. + exchange in experimental porcine cryptosporidiosis. Gastroenterology 1994;106:1418-28.
26. 26. Levine SA, Nath SK, Tse CM, et al. L-glutamine in intestinal sodium absorption: Lessons for physiology, pathobiology, and therapy for diarrhea. Gastroenterology 1994;106:1698-1713.
27. 27. Young L, Gatzen C, Wilmore K, et al. Glutamine supplementation fails to increase plasma glutamine levels in asymptomatic HIV+ individuals. JADA 1992:92(suppl):A88.
28. 28. Mebane AH. L-glutamine and mania. Am J Psychiatry 1984;141: 1302-3.